enews
International Federation of Clinical Chemistry
and Laboratory Medicine

Communications and Publications Division (CPD) of the IFCC
Editor: Katherina Psarra, MSc, PhD
IFCC Office, Via C. Farini, 81
20159 Milano, Italy
E-mail: enews@ifcc.org

news

№ 11
November 2023

1

enewsIn this issue
Editorial
Message from the eNews Editor

4

The voice of IFCCACBICON 2023, Thiruvananthapuram: a vibrant scientific hub in South India

5

Second International Nutrition Congress: From Laboratory Research to Clinical11

Studies

IFCC: the people
Farewell to Professor Jocelyn MB Hicks IFCC President 2006-2008

14

IFCC Call for Nominations

17

IFCC: the Young Scientists
Challenges of digital technologies and artificial intelligence in laboratory

19

medicine
Survey on Reporting Critical-Risk Laboratory Results

21

Contribute to IFCC eNews
Opportunity to Learn From Top Leaders in Healthcare: Join the Executive

24

Leadership Exchange

News from Regional Federations and Member Societies
XLV National Congress of Clinical Chemists CONAQUIC 2023 and new Board of26

Directors for the 2023-2025 Biennium
The Australasian Association for Clinical Biochemistry and Laboratory Medicine

30(AACB) welcomes the new President, Mr Greg Ward

2

New IFCC Members
Azerbaijan (full), Brooks Automation Italy, Controllab

31

IFCC’s Calendar of Congresses, Conferences & Events
IFCC and Regional Federations events

37

Corporate Member events with IFCC auspices

38

Other events with IFCC auspices

383

Editorial
Dear colleagues,
The November issue should have been referring to the winter, it may
be so for many of you, but winter hasn’t yet arrived in the southern
Europe. This climate change seems to be established, so don’t forget
to turn your labs into green ones.
In this issue the very long but so important and pleasant first article
by Dr Bernard Gouget takes us to the indian Karala state, (difficult toremember the name of this so interesting city, where the congress
took place). We learn about the city and the area, we learn aboutproteomics and AI, it is a journey in India and so much scientificknowledge at the same time.

Katherina Psarra, MSc,
PhD, eNews Editor

And then, go to the next article by Prof M. Iqbal Parker that introduces
us to the connection between laboratory and nutrition from acongress in Marrakech.
In this issue we pay tribute to the late Jocelyn Hicks, a model of ascientist and a woman, a very important person for IFCC. The IFCC
people were lucky to know her well, lucky was also IFCC to have her asa president, lucky us to follow her example.
The next article by the TF-YS is presenting the webinar by the young
scientists on artificial intelligence, bioinformatics and the future. Three
young ladies, scientists, following on Jocelyn’s steps are introducing
us, in three different languages, to a survey on reporting critical-risklaboratory results all over the world. Go on and respond to this survey
in your preferred language.
UNIVANTS guides us to the Executive Leadership Exchange.
And finally, reports from the Mexican and the Australasian societies,
together with new societies joining IFCC and the congresses to beheld all over the world, are closing this eNews issue.
Go on and read this new issue dear colleagues! A lot to enloy a lot togain.

Katherina

4

The voice of IFCCACBICON 2023, Thiruvananthapuram: a vibrant scientific
hub in South India
By Bernard Gouget , Chair C-MHBLM; Pradeep Dabla, Member C-MHBLM; Damien Gruson, ETD-EC liaison; Sergio Bernardini,
Chair ETD

13th-16th Sep, 2023: The 49th ACBICON 2023 in Kerala took place from September 13 to 16 at the
Al-Saj International Convention Centre in Thiruvananthapuram, the capital of Kerala. This state,situated in the southwest corner of India, is a narrow strip of land with its western coast bordering
the Arabian Sea. Thiruvananthapuram, formerly known as Trivandrum until 1991, is a distinguishedcenter for academia and research, boasting numerous universities and research institutions,
including the prestigious Indian Space Research centers such as the Indian Institute of Space
Science and Technology. The city is also a hub for media institutions, including Chitranjali Film Studio,
one of the pioneers in Malayalam cinema. As the largest city in southern India, Thiruvananthapuram
holds strategic significance, hosting the southern Air Command headquarters of the Indian Air Force.
The city was ranked among the best cities to live in India. Kerala’s Human Development Index (HDI)
rating is the highest in the country. This seemingly paradoxical phenomenon, often referred to as
the ‘Kerala phenomenon’ or the ‘Kerala model of development,’ showcases high human development
despite relatively fragile economic development. This is attributed to the dominance of the strong
service sector. Agriculture and fishing industries play a significant role in the state’s economy, nearly
half of Kerala’s population relies on agriculture as their primary source of income.
In this context, it was not surprising that the focal theme of the congress was “Laboratory Medicine
Path Ahead: Amalgamating Technology and Humanity.” This event was held under the patronageof Sri. Pinarayi Vijayan, the Chief Minister. We were warmly welcomed by His Highness Moran Mor
Athanasius Yohan I, who expressed his heartfelt gratitude in his Patron message to the ACBI fororganizing the conference in association with Believers Church Medical College Hospital (BCMCH).
Dr. George Chandy Matteethra, Director of BCMCH, emphasized the importance of focusing on thehuman touch in patient care. Dr. Seema Bhargava, President of ACBI and member of IFCC-EBLM,
along with Rajiv Ranjan Sinha, ACBI General Secretary, highlighted that the organizing committee
had the great fortune of having esteemed patrons from BCMCH, including Pr. Dr. D.M. Vasudevan as
the Organizing Chairperson, as well as the very efficient Prof. Dr. Kannan Vaidyanathan, Organizing
Secretary, and his dynamic team.

Prof Dr Kannan Vaidyanathan,The smiling and efficient ACBICON 2023 technical staff.

ACBICON 2023 organizing
secretary.

Article continued on the next page5

ACBICON 2023

The pre-conferences were thoughtfully designed to address the pressing needs of our time. The
workshops reflect our collective commitment to fostering a holistic perspective on lab medicine.
They encompassed a wide range of topics, including the clinical applications of proteomics,
genomics in infectious diseases. Healthcare isn’t one-size-fits-all, and proteomic tests can enhance
precision medicine delivered to patients. Thousands of proteins analyzed together paint a better
picture of patient health than genes or single protein tests. Adverse reactions to drugs, healthcomplications and comorbidities are determined by looking at proteins. Measuring proteins canimprove the accuracy of prognostic and diagnostic testing and can help uncover new treatment
options for patients. There is an extensive range of applications for proteomic tests covering all
aspects of human biology. Some of the most popular areas for proteomic tests are cardiovasculardisease, cancer, diabetes, kidney and liver disease, metabolic risk factors, inflammation, and immune
response.
The participants had the privilege of benefiting from the presence of an impressive panel of expert
speakers. The spectrum of information was very rich, including plenary sessions, scientific sessions,and roundtable discussions. At ACBICON congresses, it is customary to have the privilege oflistening to several brilliant plenary lectures at the beginning of each day. The K.L. Gupta Memorial
Oration was on “Recommendations and approaches in cancer” by Alpana Sharma from AIIMS Delhi.
The Dr. K.P. Sinha Oration, titled “Counting on Patients, One and All,” was presented by Tony Badrick,
APFCB President. The Taranath Shetty Memorial Oration focused on “Two Decades of Raman
Spectroscopy”. The Awadhesh Memorial Oration was centered around “Oral Cancer” and discussed
by Shyam Chauhan. The Praven Sharma Oration was presented by Poornima Manjkekar in “Diabetes2”. “Biomarkers and inflammatory skin diseases” was the topic of the Dr. G. P. Talwar Oration deliveredby Medha Rajappa. Dr. Seema Bhargava spoke brilliantly at the Dr. T.N. Patabhiraman Oration on “TheNobel laureates of biochemistry and the ‘not so Nobel’. “The four days event with the preconference workshops brought together, according to the “Veda
Exotic Holidays” team represented by Shiyas S.T., Jijin Joythi Babu, and Raj Naorayanan, nearly
1,000 participants. It was impossible to attend all the conferences. Among the topics covered weresessions on quality management, molecular diagnostics, hypercholesterolemia, inborn metabolic
disorders, biomarkers, etc... The third day of the congress was dedicated to oral presentations by
students. The exhibition halls with major IVD companies were also the venue for poster sessions,which are always enriching moments for fostering exchanges among young professionals in medical
biology. It was a great pleasure to meet again Sriram Naresh with his wife Shyamala (Photos 3, 4). Six
years ago in Mangalore, I gave him the Dr. Sita Devi Award and the ACBI Travel Fellowship Award.
During ACBICON 2023, he was selected for the Dr. DM Vasudevan Award. They make a wonderfulcouple and are exceptionally talented clinical chemists. Best wishes to both!

Anna Velts and Bernard Gouget award the Dr. Sidatevi Award

6 years later: Sriram Naresh with his wife Shyamala atand the ACBI Travel Fellowship Award to Sriram Naresh at

ACBICON 2023 in Thiruvalla, Kerala

ACBICON 2016 Mangaluru, Karnataka (IN)

Article continued on the next page

6

ACBICON 2023

Helen Martin, APFCB traveling lecturer, gave us energy by presenting the benefits and requirementsof vitamin D for optimal health. The AACC India section discussed the total testing process and thecollaboration between lab medicine and emergency medicine to ensure quality testing. IFCC had
the honor of organizing several sessions. The first was organized by the IFCC Committee on ClinicalLaboratory Management (IFCC C-CLM) with Praveen Sharma as the chair. Shruti Gupta emphasizedthat professional best practices are a managerial responsibility. Prasenjit Mitra highlighted theleadership role of medical biologists, while Sedef Yenice discussed the use of data analytics inclinical laboratories (Photo 5). Seema Bhargava chaired the IFCC-C-EBLM session on the value andevidence of laboratory testing in diabetes mellitus.
The IFCC-C MHBLM team (Photo 6) took the audience on a journey into the exciting world of “AI
Generative Intelligence for the Better! “Artificial Intelligence (AI) has tremendous potential to advanceclinical and laboratory practices, revolutionizing patient care and opening up a world of incredible
promise. Sergio Bernardini explored the role of AI and machine learning in laboratory medicine anddigital health, examining both the promise, pitfalls and potential challenges of their application
across the healthcare continuum. With the continuous expansion of technology, machine learning
offers an exciting opportunity in healthcare to enhance diagnostic accuracy, personalize healthcare,and innovate in addressing long-standing issues. However, this frontier also brings with it several
ethical considerations. For instance, the shift from human-based medical decision-making to the useof intelligent machines raises questions about privacy, transparency, and reliability.

Pradeep Dabla, Praveen Sharma, Sedef Yenice, C-CLM

Speakers’ Group at the Congress, including the IFCC-C

Speakers

MHBLM team. (L-R): Damien Gruson (BE), Bernard Gouget (FR),Seema Bhargava (IN), Helen Martin (AU), Tony Badrick (AU),Pradeep Dabla (IN)

According to Pradeep Dabla, the increasing reliance on methods of artificial intelligence to guidepatient care is not only transforming medicine but will also transform the ways in which thespecialists in Lab medicine will be trained. Future healthcare professionals will need to understandfundamental principles of data science and be capable to apply them to critically evaluate theemerging literature on AI in medicine and to do research in this emerging field.
The entire high-tech planet is in upheaval, three decades after the advent of the web, humanity is
preparing to experience a new revolution whose scale promises to be gigantic, underlined Bernard
Gouget. However, unlike the Internet, which took time to establish itself and manifest its full
effects, generative AI instantly reveals its potential. By providing free and open access to Chat GPTinterfaces for text generation and Dall-E2 for image generation, the company Open AI (USA) has
positioned itself with the most powerful testing ground. In just a few weeks, millions of people wereable to play with the technology and test its capabilities and limits. Although the technology is still
far from being stable and completely reliable, the beginnings are more than promising.

Article continued on the next page

7

ACBICON 2023

In the long run, everyone will have their own personal AI, just like everyone has their own computer.
With this AI, we will have access to information from around the world in our pockets 24/7. We will
ask any question and we will get a tailor-made answer. Today’s smartphone is equivalent to asupercomputer from ten years ago. AI will follow the same trajectory. Current AI models make factual
errors and are forgetful, but in the years to come, they will be flawless, remembering everything andadapting in a personalized way. This will be the revolution, and we will all have our personal virtualassistant, enabling us to accomplish tasks outside our area of expertise. In medicine, Chat GPT
can be incredibly valuable for a wide range of applications in the healthcare industry. Its ability tounderstand natural language and generate contextually relevant responses makes it a versatile
tool for improving patient care, assisting healthcare professionals, and enhancing overall healthcare
services. Chat GPT offers tremendous promise, but its use also entails risks and ethical challenges.
By taking a proactive approach to regulation, it will be possible to harness the potential of AI-driven
technologies while minimizing potential harm and preserving the trust of patients and healthcare
providers alike.
Damien Gruson stated that in the rapidly evolving digital age, the metaverse, has emerged as aparallel dimension with immense potential to revolutionize various aspects of society, including
laboratory medicine and patient care. By seamlessly integrating the natural and virtual worlds, themetaverse presents unparalleled opportunities for value creation and enhanced experiences. The
convergence and integration of technologies within the metaverse are set to reimagine laboratory
medicine services. Augmented services, personalized care, and unparalleled user experiences will
become the norm, revolutionizing traditional healthcare practices. In this transformative landscape,artificial intelligence, virtual reality, digital twins, and avatars will play pivotal roles. By embracing themetaverse, laboratory medicine can transcend physical limitations, breaking barriers of distanceand accessibility. Patients from remote regions can receive expert care, and collaborations between
experts.
During the conference, networking opportunities helped to shape the future and discuss various
predictions on the evolution in laboratory medicine and its subspecialties. Technological trends are
increasing laboratory capabilities. The innovative methods and equipment allow specialists in lab
medicine to work more efficiently and accurately than ever before. Smart technologies, automation,
miniaturization, and artificial intelligence are becoming real-world, streaming life in the lab.
Simultaneously, the pressure to deliver results quickly is increasing, Hence, the clinical laboratories
must be fast and agile and patient centered. That is why quality management and harmonization oftechniques at a global level are of paramount importance.
From science to South Indian cuisine, from the sophisticated art scene with Kathakali dances toarchitectural treasures and historical sites such as the Shree Padmanabhaswamy temple, a famous
Hindu temple dedicated to Maha Vishnu, there was much to discover in the capital of Kerala. Like
Reverend Father Sijo Pandapallil, Senate Member of the Kerala University of Health Sciences andManager at BCMCH, we would like to express our gratitude to all the professionals and volunteers
who worked tirelessly to make this event a reality. The congress was an excellent opportunity todemonstrate that it is both possible and desirable to work together to improve healthcare andhumanity.

Article continued on the next page8

ACBICON 2023

The Shree Padmanabhaswamy Temple

IFCC Professional Exchange Programmes (PEP)
FALL 2023 Call for Applications is OPEN
Apply for the Programme and send the completed application form to the
IFCC Office (ifcc@ifcc.org) by 30 November 2023

News from the website

9

10

Second International Nutrition Congress: From Laboratory
Research to Clinical Studies
MUMS International Convention Centre, Mashhad, Iran 4-6 October 2023
IFCC - Abbott Visiting Lecturer Programme
By Prof M. Iqbal Parker, Division of Medical Biochemistry, Department of Integrative Biomedical Sciences, Faculty of
Health Sciences, University of Cape Town Cape Town, South Africa

Title of Presentation: Genetic Polymorphisms and Molecular Pathways in Nutrition.
Lecturer: Professor M. Iqbal Parker.
The Congress, run over 3 days, was addressed by 18 international speakers, including two Nobel
laureates (Professors Kurt Wuthrich and John Walker) who gave virtual presentations. In addition,
there were 30 short workshops of about 90 minutes each interspersed before, during and after themain conference.
The main conference comprised 27 topics run in three parallel sessions. I am not sure on the numberof attendees, but I estimate that there may have been around 300-400 participants. The sessions
were well attended, and the attendance was good until the very end of the conference. Many of the
discussions in the sessions that I attended were lively. The students were very enthusiastic andclearly thirsty for knowledge they continued questions during the tea and lunch breaks.
Many of the local presenters gave talks of good scientific quality, but some of the interesting work
may have gone unnoticed by foreign delegates as many of the local talks were given in Persian.
Although the slides were in English, I think that it is crucial that young researchers become confident
in communicating in English so that their work is visible to the international scientific community.
I visited some of the institutions in Mashhad, including the International UNESCO Center for HealthRelated Basic Sciences and Human Nutrition at Mashhad University of Medical Sciences. This isa well-run facility with modest but functional and well-maintained equipment. The patient records
are still in paper format, but well secured and maintained. It is an impressive facility despite thesanctions.

Professor Iqbal Parker giving his presentation at the Congress

Prof Khosrow Adeli, IFCC President and prof Iqbal Parker VLP,
having a light-hearted discussion between sessions.

Article continued on the next page11

Second International
Nutrition Congress

Prof Adeli addressing the audience during the opening

Prof Parker with two of the local students.

ceremony.

IFCC WorldLab Dubai 2024 - Find out what awaits you!

See the video at: https://www.youtube.com/watch?v=mGuC6G5cruM

Visit the website

News from the website

12

Free Educational Webinar

TopicEnhancing Efficiency in
Quality Control Procedures
through Optimization of Resources
and Sustainable Practices

8 December 2023

2pm GMT, 3pm CET and 9am EST
Delivered by:

Oswald Sonntag

Independent Consultant

During this webinar, Oswald will present a comprehensive approach
to QC processes that integrates the principles of efficiency, costeffectiveness, and sustainability.

REGISTER NOW

13

IFCC: the people
Farewell to Professor Jocelyn MB Hicks - IFCC President
2006-2008
By Graham Beastall, IFCC Past President

Jocelyn Hicks died on 7th October 2023 at the age of 86y after a period of failing health. Jocelyn had
a long and distinguished career in laboratory medicine. She was IFCC’s first female President andwas instrumental in creating the African Federation of Clinical Chemistry.
Jocelyn was born in Leamington Spa in England (Shakespeare country) and she retained herclassical English accent throughout her life. After completing her BSc and MSc in London she moved
to Washington DC in the USA where she qualified as a clinical chemist and was based for the rest of
her life.
Jocelyn developed an interest in paediatric clinical chemistry and quickly became established
as an international expert on metabolic screening, reference values and the organisation andmanagement of paediatric laboratories. She was the Professor of Pediatrics and Pathology at theGeorge Washington University Medical Center. She published extensively and was an invited guest
speaker at many national and international conferences.
Jocelyn held numerous roles within the Association of Diagnostics and Laboratory Medicine (formerly
AACC). Starting at local level she soon became involved in publications at national level, before
joining the Board of Directors from 1978 to 1980. She served as ADLM President in 1982; received
The ADLM Outstanding Contributions Through Service to the Profession of Clinical Chemistry Awardin 1984; and the ADLM Outstanding Contributions to Clinical Chemistry Award in 1993. She was aprominent champion and ambassador for our profession in the USA and was well respected bycolleagues across the medical spectrum.
Jocelyn became active in IFCC as Chair of the Publications Division. She was responsible, with others
for initiating the Journal of the IFCC. She joined the Executive Board as Treasurer and helped tostrengthen IFCC finances while improving governance and accountability. During this period Jocelyn
appreciated the immense contribution made to IFCC by the Office team in Milan and she always
made time to encourage and develop her friendship with ‘the IFCC ladies’.
Jocelyn served as IFCC President from 2006 to 2008. She was immensely proud to be the first
IFCC woman President and she became an inspiration for women in laboratory medicine across theworld. She received numerous honours from IFCC Member societies and developed friendships that
continued until her passing. Jocelyn also had a passion for helping developing countries to improve
the quality, delivery, and impact of laboratory medicine. She invested a great deal of personal energy
and time in Africa and the creation of the African Region of IFCC may be seen as a high point in her
distinguished career. During her Presidency Jocelyn helped to create an international consensus
on the role and measurement of HbA1c in the monitoring of diabetes, which further enhanced therole of IFCC in the world of medicine. She raised funds to introduce two series of IFCC specialised
conferences that focussed on the central role of laboratory medicine in clinical medicine.
From 2009 until 2014 Jocelyn served as Past President of IFCC. Six years as a Past President wasa huge commitment and she was the last to serve for this period as the IFCC rules were changed
to ensure that no-one could serve as President (and therefore Past President) for more than three
years. Despite her ‘six-year sentence’ Jocelyn was an ever present at IFCC Executive Board meetings
providing wisdom, positivity, and harmony to her younger, less experienced colleagues. One highlight
was when Jocelyn hosted the Board to a gourmet meal at her home in Washington, which she had

Article continued on the next page14

President 2006-2008

prepared for us with her customary attention to detail.
In 2017 Jocelyn was awarded the IFCC-Wishinsky Award for Distinguished International Service. She
treasured this award above all the others she received because ‘international service’ is a fitting
tribute to describe her stellar contribution to our profession.
Jocelyn displayed all the key characteristics of leadership. She was clear thinking, determined andextremely hard working. She was also warm-hearted, considerate, supportive of others, and greatcompany. Jocelyn will be missed, and then remembered fondly, by hundreds of international friends.
The world of laboratory medicine was improved and inspired by Jocelyn Hicks.

Prof Jocelyn MB Hicks

15

EXPANDING CAREERS IN CANADA
If you are a trained Medical Lab Technologist and meets the below
eligibility requirements, AMK Global Group offers immediate
professional opportunities in recognized medical laboratories andhospitals accross Canada.
AMK Global Group is a Regulated Immigration & Recruitment firm,
which helps professionals to start their dream career in Canada & UK.
We handle the entire process by providing recruitment services to theemployers and immigration services to the candidates, which
includes many benefits;
ELIGIBILITY REQUIREMENTSEDUCATION : DIPLOMA/ DEGREE
IELTS GENERAL : 6 BANDS EACH
EXPERIENCE : 2 YEARS RELATEDASCP(American Society of Clinical
Pathology) LICENSE PREFERRED

Regulated advice and customized immigration routes
Hassle free document collection process
Online processing of entire application
Affordable living expenses in Canada
Healthcare & Other Benefits
Bring your Spouse and Children to Canada
Road to Canadian PR/ Citizenship

CLICK HERE TO APPLY NOWIFCC Call for Nominations
Participate into IFCC activities and give your contribution! Review theopen positions and, if interested, contact your National or Corporate
Representative.
Currently following call for nominations are open:
Communications and Publications Division (CPD)•

Committee on Internet and Digital Communications (C-IDC) - webeditor position - Call for nominations letter

Please send CPD nominations to colli-lanzi@ifcc.org by 30th November

Emerging Technologies Division (ETD)•••ETD Executive Committee (ETD-EC) - 3 members + 1 corporate member - Call for nominations
letterCommittee for Emerging Technologies in Pediatric Laboratory Medicine (C-ETPLM) - 3
members - Call for nominations letter
Committee on Mobile Health and Bioengineering in Laboratory Medicine (C-MHBLM) - 2
members - Call for nominations letter

Please send ETD nominations to colli-lanzi@ifcc.org by 15th November 2023

16

IFCC Call for
Nominations

IFCC Congresses and Conferences Committee (C-CC)
1 member + 1 corporate member - Call for nominations letter
Please send C-CC Nominations to cardinale@ifcc.org by 20th November 2023

Education and Management Division (EMD)
•
•
•
•
•

Education and Management Division Executive Committee (EMD-EC) - 1 corporate member- Call for nominations letter Deadline: 15th November 2023
Education and Management Division Executive Committee (EMD-EC) - 1 member - Call for
nominations letter Deadline: 15th November 2023
Committee on Clinical Laboratory Management (C-CLM) - 1 member - Call for nominations
letter Deadline: 3rd December 2023
Committee on Evidence-Based Laboratory Medicine (C-EBLM) - 1 member - Call for
nominations letter Deadline: 5th December 2023
Committee on Point of Care Testing (C-POCT) - 1 member - Call for nominations letter Deadline:
10th December 2023

Please send EMD nominations to cardinale@ifcc.org by indicated deadlines

New Task Force on Laboratory Medicine Practice Guidelines (LMPG)
5 member positions (1 Chair and 4 Members) Call for nominations letter
Please send TF-LMPG nominations to paola.bramati@ifcc.org by 30th November 2023

For any further information on nominations, please refer to your National or Corporate
Representative - contacts are available here.

Task Force Corporate Members (TF-CM)
3 member positions: The open positions include (1) one new member position, (2) opportunity toserve as the secretary, and (3) opportunity to serve as chair - Call for nominations letter
Please send TF-CM nominations to paola.bramati@ifcc.org by 31st October 2023

Article continued on the next page

17

Satellite Meeting

SATURDAY

25th
MAY
2024
INTERNATIONAL CONGRESS
OF PEDIATRIC LABORATORYMEDICINE
TOPICS:
Immunodeficiencies
Immuno-flow cytometry in pediatriclaboratory medicine
Genomics vs Mass spectrometry
in pediatric laboratory medicine

SAV E THE DATE

Newborn Screening for SCIDs
NGS in diagnosing
undiagnosed diseases

CHAIR OFTHE CONGRESS:Tim Lang, UK
18

IFCC: the Young Scientists
Challenges of digital technologies and artificial intelligencein laboratory medicine
By Marie Lenski & Ashlin Rampul, IFCC TF-YS members

The aim of IFCC task Force – Young Scientists (IFCC TF-YS) is to ensure that young scientists makea significant and growing contribution to the activities of IFCC and to the promotion of laboratory
medicine at the centre of healthcare.
The TF-YS has organized several activities, including IFCC forum for young scientists and freewebinars with participation of YS. Today’s young scientists have shown a keen interest in digitaltechnologies and artificial intelligence and its applications in laboratory medicine. Indeed, thedigital revolution does not stop at any area of life and plays a major role in healthcare. The
young professionals and researchers in laboratory medicine have a key role in this changing lab
environment and try to seize new opportunities given by technological evolutions.
The IFCC TF-YS dedicated one forum session to this topic at the IFCC TF-YS forum of young
scientists held at the ROMA 2023 WORLDLAB EUROMEDLAB, on the 21st May 2023 in Rome, Italy.
Recently the IFCC TF-YS organized a webinar on 27 July 2023. This webinar, moderated by Dr Marie
Lenski (France) and Dr Ashlin Rampul (South Africa), both members of IFCC-TF-YS, has covered
challenges of digital technologies in laboratory medicine from several facets, including digitalcompetence, artificial intelligence, and applications of bioinformatics in routine clinical practice. This
webinar comprised of the following three presentations and was followed by a panel discussion at
the end.

Article continued on the next page19

Challenges in Lab Medicine:
Digital Tech & AI

Skills of the future – what kind of digital competence is needed?
We live in the time of digital transformation and this change will not stop at medicine either. However,the skills required for this are not adequately covered in the standard training of physicians andlaboratory personnel. But which skills are necessary and how can you learn them? Dr. Jakob Adler,
YS from Germany, answered these questions using a survey he launched together with the DGKL,
the IFCC-TF-YS, the EFLM TG-YS and other colleagues from all over the world. He showed how digitalskills can be taught, using the example of the working group he founded in Germany in 2021. He also
gave an outlook on the future plans of the international digital competence initiative launched at
EuroMedLab 2022.
Augmenting Intelligence: Basics of Artificial Intelligence in the Clinical Laboratory
Artificial Intelligence (AI) has already impacted the world we live in, and it is on the verge of an
exponential growth phase that will fundamentally change the way we interact with various areas oflife. The clinical laboratory is well positioned to harness the power of AI to improve many aspects oflaboratory medicine including test utilization, automation, error detection and results interpretation.
Dr Reinhardt Hesse, YS from South Africa, provided a high-level overview of the different branchesof AI, the current state of development of AI, and its future potential. He focused specifically on
the impact of AI on the clinical laboratory and the role that laboratorians can play in successfully
implementing AI solutions in the laboratory.
Bioinformatic infrastructure, pipelines, and impact in clinics.
Bioinformatics is a relatively new and evolving discipline that combines skills and technologies
from computer science and biology to help us better understand and interpret biological data.
One field where bioinformatics is especially useful is genomics, which can generate vast quantities
of information. From personalized medicine and genomics to disease diagnosis and treatments
improvements, Dr Augustin Boudry, YS from France, described how bioinformatics contribute topatient care and medical research. He provided an overview of pure IT and developing environment,
and then illustrated practical applications with a whole range of bioinformatics pipelines, eachspecifically designed to meet unique research needs and clinical application. He detailed a pipeline,
created in his lab, specifically designed to diagnose acute myeloid leukemia within 72 hours, apathology characterized by a complex genomic landscape, for which high-throughput sequencing
plays an essential role in classifying, predicting, and treating patients.
The webinar was attended by 750 participants, and received positive feedback from the audience.
More about IFCC TF-YS activities on IFCC website https://ifcc.org/task-force-young-scientists-tf-ys/, orfollow us on instagram (/ifcc_tfys), facebook (/ifccYOUNG), linkedin (/groups/3049837

20

Young Scientists initiative: Survey on Reporting Critical-Risk
Laboratory Results
By Judit Gonda, Hungarian YS (Hungarian Society of Laboratory Medicine, MLDT), Marie Lenski, French YS (Société
Française de Biologie Cliniques SFBC), IFCC-TF-YS member, Maria Schroeder Castagno, Uruguay YS (Asociación
Bioquímica Uruguaya ABU), IFCC C-PR and WG-FC member and TF-YS corresponding member

A survey is launched by Judit Gonda, PharmD, a Young Scientist from Hungary, that aims to get toknow the protocol and habits of Reporting Critical-Risk Laboratory Results in different countries. The
survey focuses on Laboratories performing emergency laboratory tests (Biochemistry, Hematology,
routine Coagulation, emergency Microbiology, and Toxicology tests).
Professional experience in laboratory medicine in Hungary shows that there are national
recommendations, as well as institutional protocols. The aim of this survey is:- to see whether different countries use national guidelines or whether they have any protocol intheir respective institutions- to compare the protocols between countries- to describe how critical values for tests are defined, and how they are reported to clinicians- to conclude on harmonized practical tips.
The survey is available in English, French, and Spanish.
English version: fm.addxt.com/f/?t=YOyA21
French version: fm.addxt.com/f/?t=P2mP0F
Spanish version: fm.addxt.com/f/?t=oSM3yr
It would be highly appreciated if you could take some time to fill in the survey and help with our work.
The IFCC Task Force – Young Scientists (IFCC TF-YS) supports this young scientist initiative andencourages all specialists in laboratory medicine to participate in this international survey andcontribute to the quality of scientific and clinical practice standards.
Judit Gonda, YS Hungary
Marie Lenski, YS France
Maria Eugenia Castagno, YS Uruguay

Article continued on the next page21

Young Scientists initiative

Initiative des jeunes scientifiques: Enquête sur la communication des résultats critiques de biologie
médicale
Judit Gonda, YS Hongroise (Société hongroise de médecine de laboratoire, MLDT)Marie Lenski, YS Française (Société Française de Biologie Cliniques, SFBC), IFCC-TF-YS member
Maria Schroeder Castagno, YS Uruguayenne (Asociación Bioquímica Uruguaya ABU), IFCC C-PR et
WG-FC member et TF-YS corresponding member

Un questionnaire est lancé par Judit Gonda, pharmacienne et jeune biologiste Hongroise, visant àconnaître les protocoles et pratiques de communication des résultats critiques de biologie médicale.
Le questionnaire se concentre sur les laboratoires réalisant des examens de biologie d’urgence(biochimie, cytologie, hémostase, microbiologie et toxicologie).
L’expérience en biologie médicale en Hongrie montre qu’il existe des recommandations nationales,ainsi que des protocoles institutionnels. Le but de cette enquête est :- d’identifier quelles recommandations nationales ou protocoles institutionnels sont utilisés pardifférents pays
- de comparer ces protocoles entre les pays
- de décrire comment les valeurs critiques des examens de biologie d’urgence sont définies etcomment elles sont communiquées aux cliniciens- conclure sur des conseils pratiques pour leur harmonisation
Le questionnaire est disponible en anglais, en français et en espagnol.
Version anglaise : fm.addxt.com/f/?t=YOyA21
Version française : fm.addxt.com/f/?t=P2mP0F
Version espagnole : fm.addxt.com/f/?t=oSM3yr
Nous serions très reconnaissants que vous preniez le temps de répondre au sondage.
L’IFCC Task Force – Young Scientists (IFCC TF-YS) soutient cette initiative d’une jeune biologiste etencourage tous les biologistes médicaux à participer à cette enquête internationale et à contribuer àla qualité des pratiques scientifiques et cliniques.

Iniciativa de jóvenes científicos: Encuesta sobre la presentación de informes sobre resultados delaboratorios de riesgo crítico
Judit Gonda, YS húngaro (Sociedad Húngara de Medicina de Laboratorio, MLDT)Marie Lenski, francesa YS (Société Française de Biologie Clinique, SFBC), IFCC-TF-YS member
Maria Schroeder Castagno, uruguaya YS (Asociación Bioquímica Uruguaya ABU), IFCC C-PR y WG-FC
member y TF-YS corresponding member

Judit Gonda, PharmD, una Joven Científica de Hungría, lanza una encuesta que tiene como objetivo
conocer el protocolo y los hábitos de la Notificación de Resultados de Laboratorio de Riesgo Crítico
en diferentes países. La encuesta se centra en los laboratorios que realizan pruebas de laboratorio
de emergencia (bioquímica, hematología, coagulación de rutina, microbiología de emergencia ypruebas de toxicología).

Article continued on the next page22

Young Scientists initiative

La experiencia profesional en medicina de laboratorio en Hungría demuestra que existen
recomendaciones nacionales, así como protocolos institucionales. El objetivo de esta encuesta es:- ver si diferentes países utilizan directrices nacionales o si tienen algún protocolo en su institución;- comparar los protocolos de los diferentes países- describir cómo se definen los valores críticos de las pruebas y cómo se notifican a los médicos- concluir sobre consejos prácticos armonizados.
La encuesta está disponible en inglés, francés y español.
Versión inglesa : fm.addxt.com/f/?t=YOyA21
Versión francesa : fm.addxt.com/f/?t=P2mP0F
Versión española : fm.addxt.com/f/?t=oSM3yr
Sería muy apreciado si pudiera tomarse algún tiempo para completar la encuesta y ayudar a nuestro
trabajo.
El IFCC Task Force – Young Scientists (IFCC TF-YS) apoya esta iniciativa de jóvenes científicos
y anima a todos los especialistas en medicina de laboratorio a participar en esta encuesta
internacional y contribuir a la calidad de las normas de práctica científica y clínica.

23

Contribute to IFCC eNews
Opportunity to Learn From Top Leaders in Healthcare: Jointhe Executive Leadership Exchange

The UNIVANTS of Healthcare Excellence program recognizes, amplifies and inspires replication ofbest practices involving measurably better healthcare. With hundreds of initiated applications eachyear, the UNIVANTS award program has become one the highest and most coveted team honors inhealthcare today. Cross-disciplinary engagement and collaboration is not only a key requirementfor UNIVANTS, but also an important ingredient in healthcare excellence as a whole. With that inmind, and recognizing the importance of cross-functional education, the UNIVANTS of Healthcare
Excellence program is proud to host the inaugural Executive Leadership Exchange (ELX) forum.
Available now through the year end, ELX is an inspiring and engaging educational event for
all healthcare professionals, including laboratorians, clinicians, administrators and industry
professionals. With a goal to maximize value, identify solutions that resolve care gaps and promotewellness, this must-see program features a diverse agenda, where top leaders across healthcare
share best practices, insights and opportunities for measurably better healthcare.
Faculty include more than 30 diverse and world-renown speakers, including Dr. Shannon Haymond,
Past AACC President, Quint Studer, Co-founder, Healthcare Plus Solutions Group, David Grenache,
Chief Scientific Officer, TriCore Reference laboratories, David Weiss, Senior Vice President of Player
Matters, National Basketball Association, Dr. Peter Kavsak, Professor, Pathology and Molecular
Medicine, McMaster University, Michael Dowling, President &CEO, Northwell Health, and more. No
matter your role, title, or education, the educational opportunities with ELX are vast. Registration,
which includes full access to plenary sessions, educational workshops and hot topics is NOW OPEN.
Access for registered attendees is available through until December 31st. Registered attendees canalso obtain up to 15.25 ACCENT® continuing education credits.
Additionally, and available now for on-demand viewing are two complementary sessions, including abrilliant plenary talk by Michael Dowling, President & CEO, Northwell Health. As one of the foremost
CEOs in US healthcare, Mr. Dowling shares key trends and insights from the viewpoint of leadership.
To view this complimentary session now, please visit here.
Also available for on-demand viewing is a short and dynamic conversation between Dr. Colleen
Strain, Scientific Leadership, Abbott and Paul Epner, Vice Chair, Sepsis Alliance, where they discuss
becoming power users of laboratory medicine. To view this complimentary session now, please visit
here.
To learn more, watch the complimentary sessions and to register, please visit www.healthcareELX.
com.
If interested in applying for recognition through the UNIVANTS of Healthcare Excellence award
program, please visit www.UnivantsHCE.com to learn more and apply. Applications are accepted now
through until Nov.15th.

24

ARE YOU THE NEXT

WINNER?

APPLY NOWThe UNIVANTS of Healthcare Excellence Award recognizes
teams who collaborate across disciplines and transform healthcaredelivery, and ultimately patient lives.
Does this sounds like you and your team? If so, we want to hearfrom you. To learn more and apply now through November 15
visit UnivantsHCE.com.

© 2023 Abbott. All rights reserved. ADD-132530-GBL-EN.

25

News from Regional Federations and Member
SocietiesXLV National Congress of Clinical Chemists
CONAQUIC 2023 and new Board of
Directors for the 2023-2025 Biennium
By PhD. Dinorah D. Márquez Acosta

The beautiful city of Mazatlán hosted the XLV National Congress of Clinical Chemists and ExpoQuím
2023, which had the endorsement of the International Federation of Clinical Chemistry andLaboratory Medicine IFCC and the Latin American Confederation of Clinical Biochemistry COLABIOCLI
and was held on September 11 to 16, 2023, began with three days of 17 workshops and ended withthree days of conferences in three rooms with the participation of 60 national and international
expert professors who shared their research, knowledge and experience in the area of the​​ClinicalLaboratory.

Forming the presidium in the opening ceremony by the Secretary of Health Dr. Cuitlahuac González
Galindo who attended on behalf of the Constitutional Governor of the State of Sinaloa Dr. Rubén
Rocha Moya, Edgar Augusto González Zatarain Municipal President of Mazatlán, Dr. Dinorah Dolores
Márquez Acosta president of the outgoing Board of Directors 2021-2023, Chem. Rosa María Sánchez
Bautista pro secretary of Continuing Education of CONAQUIC and Chemist Miguel Angel Rodríguez
Cebreros president of the Sinaloa College of Chemists.
The majestic International Convention Center was the setting to receive Chemists, researchers andpersonnel related to the Clinical Laboratory to carry out the conferences that were presented as
Symposiums with current and interesting topics such as Insulin Resistance, Cardiovascular Diseases,
Resistance to antibiotics, Autoimmunity and coagulation, new developments in the diagnosis ofbody fluids, diseases transmitted by vectors, kidney disease to mention just a few.

Article continued on the next page

26

CONAQUIC 2023: National
Clinical Chemists Congress

As social events, the traditional icebreaker cocktail was held where the meeting with colleagues andfriends mixed with traditional mariachi and banda music that entertained and made more than 1000
people dance, including congressmen and members of commercial houses, there was also a eventat the iconic Angela Peralta theater, erected in the Porfirian era and declared Historical Heritage of
the Nation in 1990 where you could listen to the wonderful tenor Oscar Gómez and enjoy the brilliant
participation of the municipal folkloric ballet of culture of Mazatlán directed by the maestro Javier
Arcadia and finish with the closing dance dinner.

The National Federation of Clinical Chemists CONAQUIC A.C. is made up of 36 Colleges from thedifferent States of the Mexican Republic. During the development of the LXXXV Ordinary Assemblyof Presidents, the final report of the 2021-2023 Board of Directors was carried out, chaired by Dr.
Dinorah Dolores Márquez Acosta, who also took oath to the new Board of Directors that will bechaired by Chemist Juan del Toro Herrera during the 2023-2025 biennium, and the incoming vicepresident, Chemist Saúl Luna Félix, was sworn in.

Article continued on the next page

27

CONAQUIC 2023: National
Clinical Chemists Congress

As usual, there was the presence of 36 commercial houses who willingly accompanied us andenhanced the congress by showing their equipment and the most recent technology as well asreactive inputs, computer systems, revealing the best options for the attending congressmen,
forming finally a commercial exhibition of 103 stands and 10 tables.

During the closing ceremony of the event, there was the presence of Chemist Roberto Enrique
Villarmet Framery, an award-winning chemist whose name was given to the congress in his honor.
Prizes were also awarded to the winners of research works as well as to the students who competedin the Knowledge Olympiad in which 20 teams from Universities of Oaxaca, Chiapas, the State of
Mexico, Puebla, Sonora, Guanajuato, San Luis Potosí, and Mexico City registered.

The National Federation of Clinical Chemists Conaquic holds two National Congresses a year, a
National Congress of the Analysis of Quality Assurance in the Clinical Laboratory that takes place inthe month of March and the National Congress of Clinical Chemists that takes place take place in themonth of September, so the Cities of Puebla and Morelia will host the 2024 congresses respectively.
CONAQUIC maintains its objectives of union and strengthening continuing education as well as
exalting the Clinical Laboratory professional.

Article continued on the next page

28

CONAQUIC 2023: National
Clinical Chemists Congress

Board of Directors 2021-2023

PhD. Dinorah D. Márquez Acosta

29

The Australasian Association for Clinical
Biochemistry and Laboratory Medicine(AACB) welcomes the new President,
Mr Greg Ward
By Dr Fernando San Gil, MSc PhD MAACB ARCPAChief Executive Officer Australasian Association for
Clinical Biochemistry and Laboratory Medicine

It is with great pleasure that the Australasian Association for Clinical Biochemistry and Laboratory
Medicine (AACB) welcomes the new President, Mr Greg Ward. Greg’s term as President is from 2023
to 2025.
Greg has been active in the AACB over many years at the Branch and National level, including being
the AACB Chief Examiner and Chair of the Board of Examiners. Greg has a strong focus on educationand continued involvement of the AACB in areas of scientific and medical importance for laboratory
medicine.
Greg replaces Dr Tina Yen who has served the AACB with distinction over many years in various
roles, most recently including Vice President Education and Training and most recently President
from 2021 to 2023.
The AACB welcomes Greg and looks forward to advancing the mission of the AACB of promoting
the professional development of the laboratory medicine community and improving the practice oflaboratory medicine

30New IFCC Members
IFCC WELCOMES TWO NEW CORPORATE MEMBERS

Controllab
Controllab is the largest Brazilian laboratory quality control company. Since 1977 we have beenworking with the objective of sowing quality and we are committed to taking care of life. The 45-year
history of the company is based on the commitment to offer complete and integrated solutions inquality and assertiveness of laboratory results.
The services provided by Controllab facilitate routine for laboratory accreditation processes andregulatory bodies in the broadest portfolio on the market: there are more than 3,500 tests. We are afull solution company in several segments: clinical, blood bank, veterinary, microbiology and physicalchemical tests for medicines, food, sanitizers, water and effluents, fuels and others, among services
that serve hospitals and industries.
With a focus on developing the best user experience, we help clients to provide accurate,indisputable services that stand out in the national and international markets. We have unique knowhow in quality control solutions. We have the exclusive support of important scientific societies andthe recognition of the main standards related to our performance: ISO 9001, 17025, 17034 and 17043.
Visit: controllab.com/en/

Article continued on the next page31

New IFCC
Members

Brooks Automation Italy Srl
Brooks’ Laboratory Automation Solutions fits into Brooks’ strategy to setup systems within the lab
automation segment.
The Italian Core Team of senior experts at worldwide level in Laboratory Automation solutions
represents a center of excellence in Clinical Diagnostic Lab Automation:••

Clinical Diagnostic Market deep knowledge
Strong expertise in developing full and easy reconfigurable automation, including sample &reagents management, capable to scale down to small labs with high flexibility and modularity,
allowing an affordable ROI for laboratory of every size, also in case of fast changing workflows.

Laboratory Automation Solutions team in synergy with Aim Solutions and Precise FlexTM is able tooffer complete automation solutions to end customers in clinical diagnostics and life sciences.
Visit: www.brooks.com

32

IFCC WELCOMES A NEW FULL MEMBER: AZERBAIJAN
The IFCC welcomes the Azerbaijan Society of Clinical Laboratory Specialists (ASCLS) - Azerbaijan
The “Azerbaijan Society of Clinical Laboratory Specialists (ASCLS)” is now the 97th Full Member within
the IFCC.
Best wishes for a long and fruitful participation in IFCC activities and projects for advancing
excellence in laboratory medicine for better healthcare worldwide.

33

www.dubai2024.org

26th International Congress ofClinical Chemistry and Laboratory Medicine
17th Congress of Arab Federationof Clinical Biology
10th Saudi Society for Clinical
Chemistry Annual Meeting
8th International and UAE Genetic
Disorders Conference

DEADLINES
15 January 2024
Deadline for poster abstract submission

Dubai World
Trade Centre (DWTC)

15 March 2024
Deadline for reduced registration fees
The Preliminary Program is now
available on the congress website!

34

News from the IFCC Website

Click here for the on-demand content
The webinar on “Interference on high sensitivity troponin assays” gives an overview of analyticaland biological interference affecting troponin assays, the analytical methods needed to detect
interference and further discuss the clinical consequences of troponin interference and discuss aand potential biological meaning of detecting such results.
It comprises of three following presentations of 20 min each
Moderator: Dr. Kristin Moberg Aakre (Norway)
Talk 1: Analytical and biological interferences for cardiac troponin assays; what should we look out for
and when? Dr. Pete Kavsak (Canada)
Talk 2: Detecting troponin interferences; recommendations for the routine laboratory Prof. Ola
Hammarsten (Romania)
Talk 3: When clinically can macrotroponins be confounding? Dr. Allan S. Jaffe (USA)

Article continued on the next page

35

News from the IFCC Website

On demand content available!
Pediatrics is an area where emerging technologies have been implemented successfully to address
the needs of this specific population. The IFCC Emerging Technologies Division has recently
defined an emerging technology as “an analytical method or device that by virtue of its stageof development, translation into broad routine clinical practice, or geographical adoption andimplementation has the potential to add value to clinical practice.” The role of emerging technologies
and its introduction throughout the diagnostic cycle will be discussed using examples in the generallaboratory and those laboratories supporting regional and national programs such as newborn
bloodspot screening and rare disease programs.
This webinar comprises of three following presentations of 20 min each followed by 20 min of panel
discussion at the end.
Chair: Prof. Klaus Kohse
Talk 1- “Emerging technologies supporting pediatric laboratory medicine - Dr. Tim Lang
Talk 2- “The Impact of Genomics and Transcriptomics in Pediatric Clinical Care” - Dr. Lianna
Kyriakopoulou
Talk 3- “Optimising second-tier newborn screening for congenital adrenal hyperplasia?”- Prof. Ronda
Greaves36

IFCC’s Calendar of Congresses,
Conferences & Events
IFCC and Regional Federation
Events
Date

Title

Place

Dec 4,- Dec 52023

2023 JCTLM Workshop on: ‘EQA
schemes elucidating the clinicalsuitability of laboratory results’Sèvres,FR

Jan 25, - Jan 26
2024

AFCC CONGRESS 2024

Cairo,EG

May 25,2024

XVII ICPLM - INTERNATIONALCONGRESS OF PEDIATRICLABORATORY MEDICINE

Dubai,UAE

May 26 - Jun 30,
2024

XXVI IFCC WORLDLAB Dubai 2024

Dubai,UAE

May 26, - Jun 30
2024

AFCB Congress in conjunction
with the XXVI IFCC WorldLab
Dubai 2024 Congress

Dubai,UAE

Oct 3 - 6,
2024

XXVI COLABIOCLI 2024

Cartagena,
CO

October 31 Nov 3, 2024

APFCB 2024 Sydney

Sidney,AU

May 18 - 22,
2025

XXVI IFCC-EFLM
EUROMEDLAB 2025

Brussels,
BE

Article continued on the next page37

Corporate Member Events with
IFCC Auspices
Date

Title

Place

Nov 18,2023

Inter-QC Topics

Quality
Academics,
online, MX

Nov 25,2023

International Symposium on
Laboratory Medicine

Snibe,
Kathmandu,NP

Nov 30,2023

International Symposium on
Laboratory Medicine

Snibe,
Madrid, ES

Dec 15,2023

International Symposium on
Laboratory Medicine

Snibe,
Bucharest,
RO

Other events with
IFCC auspices
Click here38

Published ten times a year:

Advertise in
IFCC eNews!
Showcase your products and initiatives
to more than 49.000 laboratory medicine
specialists throughout Europe, North
America, Asia- Pacific, Middle East, Africa
and Latin America: laboratory directors,
clinical chemists, and other clinicallaboratory specialists and technologists,
leading manufacturers, distributors anddealers in the field.
• Ten issues per year
• Free-of-charge to readers• Interactive digital edition

No 1/2
No3
No 4
No5
No 6
No 7/8
No9
No 10
No 11
No 12

January/February
March
April
May
June
July/August
September
OctoberNovember
December

For prices, formats and any further information
on how your company can gain unique access\tointernational markets through advertsingwith IFCC, please email us at enews@ifcc.org.
IFCC Corporate Members receive a 25%
discount on current prices.

39

IFCC Executive Board 2021 - 2023

Khosrow
ADELI
President

TomrisOZBEN
President-electDavid
KINNIBURGH
SecretaryAlexander
HALIASSOS
Treasurer

JosephPASSARELLI
Corporate
Representative

E. HOYARANDA
Asia-Pacific Fed
for Clin Biochem
and Lab Med(APFCB)

A. M. ŠIMUNDIĆ
European Fed ofClin Chem andLab Medicine(EFLM)

A.M. LENA
Latin-American
Confederationof Clin
Biochemistry(COLABIOCLI)T. PILLAY (ZA)
Communications
andPublications
Division Chair

S. BERNARDINI (IT)
Emerging
Technologies
Division Chair

P. LAITINEN (FI)Congresses andConferences
Committee Chair

Regional Representatives

AB OKESINA
AfricanFederation ofClinical Chemistry(AFCC)

A. HEDHILI
Arab
Federation ofClinical Biology(AFCB)

E. DUNN
North American
Fed of Clin
Chem and Lab
Med(NAFCC)IFCC Divisions and C-CC Chairs

C. COBBAERT (NL)
Scientific
Division Chair

N. RIFAI (US)
Education andManagement
Division Chair

IFCC Office Staff(L-R) Elisa Fossati, Paola Bramati, Silvia Colli Lanzi,
Silvia Cardinale, Smeralda Skenderaj, Sofia Giardina

40

IFCC Membership
Full members

Albania (AL)
Algeria (DZ)
Argentina (AR)Armenia (AM)Australasia and New
Zealand (AU/NZ)
Austria (AT)Azerbaijan (AZ)
Belgium (BE)Bolivia (BO)
Bosnia Herzegovina (BA)
Brazil (BR)
Bulgaria (BG)
Canada (CA)Chile (CL)
China Beijing (CN)China Taipei (TW)
Colombia (CO)Croatia (HR)Cuba (CU)
Cyprus (CY)
Czech Republic (CZ)
Denmark (DK)
Dominican Rep (DO)
Ecuador (EC)Egypt (EG)Estonia (EE)
Ethiopia (ET)Finland (FI)France (FR)Georgia (GE)Germany (DE)Greece (GR)
Guatemala (GT)Hong Kong (HK)
Hungary (HU)
Iceland (IS)India (IN)Indonesia (ID)
Iran (IR)Iraq (IQ)
Ireland (IE)
Israel (IL)
Italy (IT)Japan (JP)Jordan (JO)
Kazakhstan (KZ)
Kenya (KE)
Korea (KR)Corporate members

Kosovo (XK)
Latvia (LV)
Lebanon (LB)
Libya (LY)
Lithuania (LT)
Luxembourg (LU)
Malawi (MW)Malaysia (MY)Mexico (MX)Montenegro (ME)
Morocco (MA)
Myanmar (MM)
Nepal (NP)
Netherlands (NL)
Nigeria (NG)North Macedonia (MK)Norway (NO)Pakistan (PK)Palestine (PS)Panama (PA)Paraguay (PY)
Peru (PE)Philippines (PH)Poland (PL)Portugal (PT)
Romania RO)
Russia (RU)
Saudi Arabia (SA)Serbia (SRB)
Singapore (SG)Slovak Republic (SK)Slovenia (SI)South Africa (ZA)
Spain (ES)Sri Lanka (LK)
Sudan (SD)
Sweden (SW)Switzerland (CH)
Syrian Arab Republic (SY)
Thailand (TH)Tunisia (TN)Türkiye (TR)Ukraine (UA)United Kingdom (UK)
United States (US)Uruguay (UY)
Vietnam (VN)
Zambia (ZM)
Zimbabwe (ZW)

Regional Federations

Arab Federation of Clinical Biology (AFCB)
African Federation of Clinical Chemistry (AFCC)
Asia-Pacific Federation for Clinical Biochemistry
and Laboratory Medicine (APFCB)
European Federation of Clinical Chemistry
and Laboratory Medicine (EFLM)
Latin America Confederationof Clinical Biochemistry (COLABIOCLI)North American Federation of Clinical Chemistry
and Laboratory Medicine (NAFCC)

Abbott Laboratories
Agappe Diagnostics Ltd
Arkray Inc.
Asahi Kasei Pharma Corp.
Autobio Diagnostics Co. Ltd.
Bd Diagnostics-Preanalytical
Systems
Beckman Coulter, Inc.
Bio Rad Laboratories
Biomasterclin Laboratorios
Venezuela
Brooks Automation Italy Srl
Controllab
C.P.M. Compagnia Per La
Medicina® Srl
Dia Sys Diagnostic Systems
Gmbh
Diagnostica Stago
Diasorin Spa
Et Healthcare Inc.
Fujifilm Wako Pure Chemical
Corporation
Fujirebio-Europe
Gentian As
Helena Biosciencies Europe
Hemas Hospital Pvt
Hytest Ltd.
Immunodiagnostic Systems
Instrumentation Laboratory
I-Sens, Inc.
Jiangsu Bioperfectus
Technologies Co. Ltd.
Labor Team W Ag
Lumiradx Uk Ltd.
Maccura Biotechnology Co.,Ltd.
Medicalsystem Biotechnology
Co., Ltd.
Medix Biochemica
Menarini Diagnostics
Mindray
Nittobo Medical Co. Ltd.
Oneworld Accuracy
Quidelortho
Perkinelmer
Phc Europe B.V.
Quality Academics
Radiometer Medical Aps
Randox Laboratories Ltd.
Roche Diagnostics Gmbh
Sansure Biotech Inc
Sebia S.A.
Sentinel Ch Spa
Shanghai KehuaBioengineering Co., Ltd.
Shenzhen Yhlo Biotech
Siemens Healthcare
Diagnostics
Snibe Co., Ltd
Synlab International Gmbh
Sysmex Europe Gmbh
Technogenetics
The Binding Site Group Ltd.
Thermo Fisher ScientificTosoh Corporation
United Robotics Group Gmbh
Wisplinghoff
Laboratoriumsmedizin Koeln
Wuhan Life Origin Biotech Joint
Stock Co., Ltd. - Sybio

Affiliate Members

Botswana: Institute of Clinical Laboratory Professionals
Brazil: Sociedade Brasileira de Patologia Clínica / Medicina
Laboratorial (SBPC/ML)
China: Lab Medicine Committee, China Association of Medical
Equipment (LMC)
Egypt: Egyptian Association of Healthcare Quality and Patient
SafetyFrance: French National Network of Accredited Laboratories ofMedical Biology (LABAC)
India: Association of Medical Biochemists of India (AMBI)
Iran: Iranian Association of Clinical Laboratory Doctors (IACLD)
Jordan: Society for Medical Technology & Laboratories (SMTL)
Kazakhstan: Public Association - Federation of Laboratory
Medicine (FLM)
Mexico: Federación Nacional de Químicos Clínicos (CONAQUIC
A.C.)
Mexico: Colegio Nacional de Químicos Clínicos en Medicina deLaboratorio (CONQUILAB)
Mexico: Federación Nacional de Colegios Profesionales de laQuímica Clínica, A.C. (FENACQC)
Nepal: Nepalese Association for Clinical Chemistry (NACC)
Philippines: Philippine Council for Quality Assurance in ClinicalLaboratories (PCQACL)
Romania: Order of the Biochemists, Biologists, Chemists in
Romanian Health System (OBBCSSR) Serbia: Serbian Society for
Clinical Laboratory Medicine and Science (SCLM)
Spain: Andalusian Society for Clinical Analysis and Laboratory
Medicine (SANAC)
Spain: Asociación Española de Biopatología Médica - Medicinade Laboratorio (AEBM-ML)
Spain: Asociación Española de Farmacéuticos Analistas (AEFA)
Sri Lanka: College of Chemical Pathologists of Sri Lanka (CCPSL)
Türkiye: Society of Clinical Biochemistry Specialists (KBUD)
Ukraine: Association for Quality Assurance of Laboratory
Medicine (AQALM)
United Arab Emirates: Genetic Diseases Association (UAEGDA)

41

enewsPublisher
Communications and Publications Division(CPD) of the IFCCThe Communications and Publications
Division publishes ten editions of the e-Newsper year, including two double issues.
EditorKatherina Psarra, MSc, PhD
Department of Immunology Histocompatibility Evangelismos Hospital,
Athens, Greece
E-mail: enews@ifcc.org
The eNews is distributed to all IFCC
members registered on-line to receive it andto all IFCC sponsors.
Deadlines for submissions to the eNews
N° 1/2 – January/February: by mid January
N° 3 – March: by mid February
N° 4 – April: by mid March
N° 5 – May: by mid April
N° 6 – June: by mid May
N° 7/8 – July/August: by mid June
N° 9 – September: by mid August
N° 10 – October: by mid September
N° 11 – November: by mid October
N° 12 – December: by mid November
If you want to submit an article oradvertisement to be published in the eNews,
send it to: Katherina Psarra, Editor, IFCC
eNews
E-mail: enews@ifcc.org

Copyright © 2023 IFCC. All rights reserved.
Contents may not be reproduced without
the prior permission of the Communications
and Publications Division (CPD) of the IFCC.

42